Who owns Oncothyreon?
Key information on Oncothyreon (Ticker: ONTY)
- CUSIP: 682324108
Who owns Oncothyreon?
Is ONTY a good stock to own? Find out who bought Oncothyreon, who sold Oncothyreon (ONTY) stock, and who holds a large position in Oncothyreon.
- BVF owns 3.58M shares worth $7.45M
- Antipodean Advisors owns 2.30M shares worth $13.77M
- Ayer Capital Management owns 2.20M shares worth $11.30M
- Jefferies owns 1.64M shares worth $3.14M
- State of Wisconsin Investment Board owns 1.55M shares worth $3.22M
- Vanguard owns 1.54M shares worth $3.23M
- OrbiMed Advisors owns 1.52M shares worth $7.81M
- Deerfield Management Company owns 1.50M shares worth $6.54M
- BAM Management owns 1.25M shares worth $7.46M
- Renaissance Technologies owns 1.00M shares worth $2.09M
- Tang Capital Management owns 984980 shares worth $2.05M
- Adage Capital Partners GP owns 950000 shares worth $1.97M
- STATE STREET CORPORATION owns 836579 shares worth $1.74M
- Anthion Management owns 775400 shares worth $3.38M
- Broadfin Capital owns 750000 shares worth $1.44M
- CITADEL ADVISORS owns 710761 shares worth $1.48M
- D. E. Shaw & Co owns 690365 shares worth $1.44M
- Dr. Jeffrey R. Jay, M.D. owns 605774 shares worth $1.26M
- Dr. Jeffrey R. Jay, M.D owns 605774 shares worth $1.26M
- "Perkins Capital Management, Inc." owns 540376 shares worth $1.04M
- JPMORGAN CHASE & CO owns 533448 shares worth $2.50M
- Arrow Capital Management owns 519400 shares worth $3.94M
- Barclays owns 510000 shares worth $1.06M
- Sabby Management owns 451741 shares worth $867342
- Hudson Bay Capital Management owns 413100 shares worth $1.80M
- GOLDMAN SACHS owns 408994 shares worth $785268
- 683 Capital Management owns 404300 shares worth $3.06M
- Balyasny Asset Management owns 293341 shares worth $563214
- Oxford Asset Management owns 290427 shares worth $2.20M
- Bridgeway Capital Management owns 282300 shares worth $542016
- Straus Capital Management owns 254155 shares worth $487977
- Suffolk Capital Management owns 235650 shares worth $490152
- TIAA-CREF Investment Management owns 235216 shares worth $489249
- AQR Capital Management owns 228559 shares worth $996517
- Allianz Asset Management AG owns 222000 shares worth $461760
- Mangrove Partners owns 221600 shares worth $425472
- UBS AG owns 219495 shares worth $456549
- Jacobs Levy Equity Management owns 211380 shares worth $405849
- First Eagle Investment Management owns 200000 shares worth $416000
- Driehaus Capital Management owns 198160 shares worth $1.50M
- Perceptive Advisors owns 197700 shares worth $379584
- Geode Capital Management owns 185523 shares worth $385887
- Bank of America Corporation owns 162017 shares worth $831147
- --- -------------------- ----- owns 150000 shares worth $1.14M
- Cowen owns 149853 shares worth $768745
Who sold Oncothyreon?
- Black Horse Capital Management sold on June 30, 2011
- RA Capital Management sold on March 31, 2011
- Alphabet Management sold on March 31, 2011
Funds that own ONTY also own:
- BP (BP)
- Companhia de Bebidas das Americas (ABV)
- Teva Pharmaceutical Industries (TEVA)
- Cardinal Health (CAH)
- McKesson Corporation (MCK)
- CIGNA Corporation (CI)
- Array BioPharma (ARRY)
- Vanda Pharmaceuticals (VNDA)
- Celgene Corporation (CELG)
- ISIS Pharmaceuticals (ISIS)
- Nektar Therapeutics (NKTR)
- Pain Therapeutics (PTIE)
- NPS Pharmaceuticals (NPSP)
- Rigel Pharmaceuticals (RIGL)
- Targacept (TRGT)
- Flamel Technologies S.A. (FLML)
- Ariad Pharmaceuticals (ARIA)
- iShares iBoxx $ High Yid Corp Bond (HYG)
- Palatin Technologies (PTN)
- Threshold Pharmaceuticals (THLD)
- Oncothyreon (ONTY)